Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q4 EPS by 131c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $87.11 -0.41%
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Change in value of derivatives: -113.36K
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q4 EPS of ($1.92), $1.31 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $240.73 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Is the global equity rally broadening? UBS weighs in
- BofA maintains underperform ratings on six BDC stocks
- Baird Starts Jersey Mike's Subs (JMKE) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
